| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Friday’s Close |
|---|---|---|---|---|---|
| SNY | Sanofi | $43.75 | $109.14B | N/A |
Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod
http://www.zacks.com/stock/news/432688/pharma-stock-roundup-pfe-to-buy-arry-rhhby-mrk-azn-drugs-get-regulatory-nod?cid=CS-ZC-FT-432688
Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
0
The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens
http://www.zacks.com/stock/news/432215/the-zacks-analyst-blog-highlights-alphabet-amazon-apple-sanofi-and-walgreens?cid=CS-ZC-FT-432215
Jun 20, 2019 - The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens
0
Sanofi Partners Google to Build Healthcare Innovation Lab
http://www.zacks.com/stock/news/431152/sanofi-partners-google-to-build-healthcare-innovation-lab?cid=CS-ZC-FT-431152
Jun 18, 2019 - Sanofi (SNY) signs a partnership pact with Google to develop a new virtual healthcare innovation lab for modernizing future medicines and healthcare services with sophisticated data technologies.
0
Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients
http://www.zacks.com/stock/news/431041/novo-nordisks-victoza-gets-fda-nod-for-pediatric-patients?cid=CS-ZC-FT-431041
Jun 18, 2019 - Novo Nordisk's (NVO) Victoza gets FDA approval for the treatment of pediatric patients aged 10 years or older with type II diabetes.
0
Regeneron (REGN) Presents Positive Data on Lymphoma Candidate
http://www.zacks.com/stock/news/430443/regeneron-regn-presents-positive-data-on-lymphoma-candidate?cid=CS-ZC-FT-430443
Jun 17, 2019 - Regeneron (REGN) reports positive early-stage data on REGN1979 in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma.
0
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod
http://www.zacks.com/stock/news/429560/pharma-stock-roundup-mrk-buys-small-cancer-biotech-rhhby-mrk-drugs-get-fda-nod?cid=CS-ZC-FT-429560
Jun 14, 2019 - Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.
0
Lilly Announces Tradjenta Cardiovascular Outcome Study Data
http://www.zacks.com/stock/news/427738/lilly-announces-tradjenta-cardiovascular-outcome-study-data?cid=CS-ZC-FT-427738
Jun 11, 2019 - Tradjenta leads to fewer events of hypoglycemia and modest weight reduction in type II diabetes patients compared to Sanofi's Amaryl.
0
Sanofi (SNY) in Focus: Stock Moves 5.5% Higher
http://www.zacks.com/stock/news/427295/sanofi-sny-in-focus-stock-moves-55-higher?cid=CS-ZC-FT-427295
Jun 10, 2019 - Sanofi (SNY) shares rose nearly 6% in the last trading session, amid huge volumes.
0
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache
http://www.zacks.com/stock/news/426292/pharma-stock-roundup-asco-update-fda-nod-for-llys-emgality-for-cluster-headache?cid=CS-ZC-FT-426292
Jun 07, 2019 - Pharma bigwigs present data from cancer studies at ASCO. Lilly's (LLY) CGRP Emgality gets FDA approval for episodic cluster headache in adults.
0
Novartis Appoints New Pharma Unit Head, Gives Other Updates
http://www.zacks.com/stock/news/426279/novartis-appoints-new-pharma-unit-head-gives-other-updates?cid=CS-ZC-FT-426279
Jun 07, 2019 - Novartis (NVS) appoints Marie-France Tschudin as head of the pharma unit. The company also provides a few pipeline updates.
0
Page 1>